Truvestments Capital LLC Gilead Sciences, Inc. Transaction History

Truvestments Capital LLC

$376 Million
Q4 2024

A detailed history of Truvestments Capital LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 1,603 shares of GILD stock, worth $153,054. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,603

Previous 1,499 6.94%

Holding current value

$153,054

Previous $125,000 18.4%

% of portfolio

0.04%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$83.95 - $97.9 $8,730 - $10,181	104 Added 6.94%	1,603 $148,000
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $99,818 - $125,901	1,499 New	1,499 $125,000
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $6,084 - $7,419	85 Added 6.11%	1,476 $108,000
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $56,784 - $64,394	775 Added 125.81%	1,391 $112,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $1,035 - $1,129	-14 Reduced 2.22%	616 $46,000
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $13,301 - $15,172	175 Added 38.46%	630 $48,000
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $18,322 - $20,874	-237 Reduced 34.25%	455 $37,000
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $2,305 - $3,310	37 Added 5.65%	692 $59,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $11,848 - $13,533	-199 Reduced 23.3%	655 $40,000
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $49,292 - $55,518	854 New	854 $53,000
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $49,174 - $61,620	-849 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $29,650 - $33,653	457 Added 116.58%	849 $62,000
Q3 2021 Oct 29, 2021	BUY	$67.69 - $73.03 $135 - $146	2 Added 0.51%	392 $27,000
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $120,212 - $131,348	-1,894 Reduced 82.92%	390 $27,000
Q1 2021 May 18, 2021	BUY	$60.0 - $68.46 $120 - $136	2 Added 0.09%	2,284 $148,000
Q4 2020 Feb 17, 2021	BUY	$56.65 - $64.55 $31,950 - $36,406	564 Added 32.83%	2,282 $132,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $2,049 - $2,576	33 Added 1.96%	1,718 $109,000
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $25,029 - $29,064	-346 Reduced 17.04%	1,685 $129,000
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $127,201 - $162,926	2,031 New	2,031 $151,000
Q4 2019 Jan 29, 2020	SELL	$61.62 - $67.78 $100,255 - $110,278	-1,627 Closed	0 $0
Q3 2019 Oct 10, 2019	BUY	$62.51 - $69.0 $125 - $138	2 Added 0.12%	1,627 $103,000
Q2 2019 Jul 15, 2019	SELL	$61.87 - $69.38 $7,919 - $8,880	-128 Reduced 7.3%	1,625 $110,000
Q1 2019 Apr 12, 2019	SELL	$62.53 - $70.05 $60,841 - $68,158	-973 Reduced 35.69%	1,753 $114,000
Q3 2018 Oct 22, 2018	BUY	$71.28 - $78.92 $194,309 - $215,135	2,726 New	2,726 $210,000

Others Institutions Holding GILD

# of Institutions

1,993

Shares Held

993M

Call Options Held

10.1M

Put Options Held

8.85M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $120B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.

Account

Truvestments Capital LLC Gilead Sciences, Inc. Transaction History